{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:20:36Z","timestamp":1794669636192,"version":"4.9.1"},"reference-count":59,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,4,11]],"date-time":"2003-04-11T00:00:00Z","timestamp":1050019200000},"content-version":"vor","delay-in-days":69,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Apheresis has been recognized both economically and therapeuticallyas a novel approach for the treatment of inflammatory diseases,and certain others, which respond poorly to drug therapy. This reportis about Adacolumn, an adsorptive carrier based granulocyteand monocyte apheresis device with a volume of 335\u2003mL,filled with about 220\u2003g of cellulose acetate beads of 2\u2003mmdiameter as the column adsorptive carriers. Pre\u2010 and post\u2010columnleukocyte counts have shown that the carriers adsorb about 65% ofgranulocytes, 55% of monocytes and 2% of lymphocytesfrom the blood in the column. Additionally, after apheresis, thereis a marked decrease in inflammatory cytokines (TNF\u2010\u03b1,IL\u20101\u03b2, IL\u20106 and IL\u20108) produced by blood leukocytes,together with down\u2010modulation of <jats:sc>l<\/jats:sc>\u2010selectinand the chemokine receptor CXCR3. Adacolumn has been used to treatpatients with rheumatoid arthritis, ulcerative colitis and HIV infection. Typicalapheresis sessions have been 4\u201310, at a frequency of oneor two sessions per week. Treatment of patients with Adacolumn hasbeen associated with very promising efficacy and safety data. Accordingly,in Japan, Adacolumn has been approved by the Ministry of Healthfor the treatment of ulcerative colitis. Furthermore, Adacolumnmet the required quality and safety standards for medical devices andreceived an EC certification (CE\u2010mark) from TUV in 1999. However,although Adacolumn carriers are very efficient in depleting excessand activated granulocytes and monocytes\/macrophages, theclinical efficacy associated with Adacolumn apheresis cannot befully explained on the basis of reducing granulocytes and monocytesper se. Hence, a long lasting effect on inflammatory cytokine generation,chemokine activities or immunomodulation is likely, but the precisemechanisms involved are not fully understood yet.<\/jats:p>","DOI":"10.1046\/j.1526-0968.2003.00012.x","type":"journal-article","created":{"date-parts":[[2004,12,29]],"date-time":"2004-12-29T16:07:46Z","timestamp":1104336466000},"page":"48-59","source":"Crossref","is-referenced-by-count":221,"title":["Adacolumn, an Adsorptive Carrier Based Granulocyte and MonocyteApheresis Device for the Treatment of Inflammatory and RefractoryDiseases Associated with Leukocytes"],"prefix":"10.1111","volume":"7","author":[{"given":"Abby R","family":"Saniabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvar","family":"Bjarnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lofberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,4,11]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31291142942.x"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31291142958.x"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1997.tb00513.x"},{"key":"e_1_2_9_5_2","first-page":"117","article-title":"Granulocytapheresisin active ulcerative colitis. A multicenter randomized control study","volume":"18","author":"Shimoyama T","year":"1999","journal-title":"Jpn J Apher"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.1000"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020159932758"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/jcgh.2003.50005"},{"key":"e_1_2_9_9_2","first-page":"173","article-title":"Human neutrophil Fc receptor mediated adhesion underflow: a hallow fiber model of intravascular arrest. Clin ExpImmuno","volume":"100","author":"D\u2019Arrigo C","year":"1994","journal-title":"l"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(97)01087-6"},{"key":"e_1_2_9_11_2","first-page":"2133","article-title":"Biphasic production of IL\u20108 in lipopolysaccharide (LPS) stimulatedhuman whole blood","volume":"148","author":"DeForge L","year":"1992","journal-title":"J Immunol"},{"key":"e_1_2_9_12_2","first-page":"1691","article-title":"Pathogenesis of ulcerative colitis (UC): enhanced formationof inositol phosphate (IP) and platelet activating factor (PAF)","volume":"92","author":"Wengrower D","year":"1987","journal-title":"Gastroentrology"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00290518"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb02958.x"},{"key":"e_1_2_9_15_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00054725-200002000-00004","article-title":"Thekey role of macrophages in the immunopathogenesis of inflammatorybowel disease","volume":"6","author":"Mahida YR","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90285-8"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.5.669"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1992.tb39753.x"},{"key":"e_1_2_9_19_2","first-page":"91","volume-title":"InflammatoryBowel Disease","author":"Allison MC","year":"1998"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(95)80066-2"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.4.470"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.51.1.289"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010659803912"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1998.tb00091.x"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050068"},{"key":"e_1_2_9_26_2","first-page":"57","article-title":"Clinicalefficacy of an extracorporeal granulocyte removal column (G\u20101) onrheumatoid arthritis: a multicenter clinical study","volume":"17","author":"Kasukawa R","year":"1997","journal-title":"Jpn JInflamm"},{"key":"e_1_2_9_27_2","first-page":"647","volume-title":"Therapeutic Plasmapheresis","author":"Agishi T","year":"1993"},{"key":"e_1_2_9_28_2","first-page":"985","article-title":"Granulocytapheresisas a possible cancer treatment","volume":"15","author":"Tabuchi T","year":"1995","journal-title":"Anticancer Res"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1500.1999.99029.x"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015330816364"},{"key":"e_1_2_9_31_2","first-page":"173","article-title":"Efficacy of extracorporeal granulotrap G\u20101 column in a rabbitmodel of induced arthritis","volume":"16","author":"Saniabadi AR","year":"1997","journal-title":"Jpn J Apheresis"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.1008"},{"key":"e_1_2_9_33_2","first-page":"27","article-title":"Ex\u2010vivo purging of circulatingmonocytes results in immunovirologic improvement in partially HAARTresponder HIV infected patients","volume":"14","author":"Beretta A","year":"2000","journal-title":"J Biol Regul Homeost Agents"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1191\/0267659102pf559oa"},{"key":"e_1_2_9_35_2","first-page":"58","article-title":"Granulocyte\/monocyteapheresis induces sustained increases in CD4 T cells in HIV\u2010infectedpatients: with poor CD4 restoration after suppression of viral replicationby HAART","volume":"16","author":"Hasson H","year":"2002","journal-title":"J Biol Regul Homeost Agents"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1998.tb00082.x"},{"key":"e_1_2_9_37_2","first-page":"in","article-title":"Granulocytapheresisfor Crohn's Disease: a report on seven refractory patients","volume":"98","author":"Matsui T","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120597"},{"key":"e_1_2_9_39_2","first-page":"in","article-title":"Successfultreatment of pustular psoriasis with granulocyte and monocyte adsorptionapheresis","volume":"48","author":"Kanekura T","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_9_40_2","first-page":"in","article-title":"A new treatment for HCV\u2010ulcerativecolitis co\u2010morbidity intolerant to INF\u2010\u03b1","volume":"98","author":"Sawada K","year":"2003","journal-title":"AmJ Gastroenterol"},{"key":"e_1_2_9_41_2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4049\/jimmunol.153.4.1769","article-title":"Reconstitutionof antibody\u2010dependent phagocytosis in fibroblasts expressing Fcgamma receptor IIIB and the complement receptor type 3","volume":"153","author":"Krauss JC","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6666.82"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712243172603"},{"key":"e_1_2_9_44_2","first-page":"393","article-title":"Thevalue of rectal biopsy in the diagnosis of ulcerative colitis","volume":"120","author":"Matts SGF","year":"1961","journal-title":"Q J Med"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780242"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(200108)194:4<393::AID-PATH907>3.0.CO;2-7"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01430.x"},{"key":"e_1_2_9_48_2","unstructured":"BiswasP LazzarinA BerettaA.Selective down\u2010modulation ofCXCR3 and CXCR4 in drug resistant patients subjected to structuredtreatment interruptions plus specific granulocyte and monocyte apheresis.Proceedings of the 7th European Conference on ExperimentalAIDS Research.8\u201311 June 2002; Genoa Italy: Abstract WS5."},{"key":"e_1_2_9_49_2","first-page":"356","article-title":"Peripheralblood neutrophils from hepatitis C virus\u2010infected patients are replicationsites for the virus","volume":"85","author":"Cravatto M","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1095"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.6.1276"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-200005000-00003"},{"key":"e_1_2_9_53_2","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.156.11.4422","article-title":"Opposing effects of glucocorticoidson the rate of appoptosis in neutrophilic and eosinophilic granulocytes","volume":"156","author":"Meagher LC","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.54.4.283"},{"key":"e_1_2_9_55_2","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.4049\/jimmunol.157.12.5660","article-title":"CR3 (alphaM beta2; CD11b\/CD18)restores IgG\u2010dependent phagocytosis in transfectants expressinga phagocytosis\u2010defective Fc gammaRIIA (CD32) tail\u2010minus mutant","volume":"157","author":"Worth RG","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(99)00041-3"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)01036-E"},{"key":"e_1_2_9_58_2","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1182\/blood.V92.8.2823","article-title":"Aregulatory role for Fcgamma receptors CD16 and CD32 in the developmentof murine B cells","volume":"92","author":"De Andres B","year":"1998","journal-title":"Blood"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.3109\/08830180109054414"},{"key":"e_1_2_9_60_2","first-page":"145","article-title":"Internationalunion of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy PM","year":"2000","journal-title":"Pharmacol Rev"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-0968.2003.00012.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:07:23Z","timestamp":1697314043000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-0968.2003.00012.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1046\/j.1526-0968.2003.00012.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-0968.2003.00012.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}